BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36639673)

  • 1. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.
    Ohashi Y; Toyoda M; Saito N; Koizumi M; Kanai G; Komaba H; Kimura M; Wada T; Takahashi H; Takahashi Y; Ishida N; Kakuta T; Fukagawa M; Ichida K
    Sci Rep; 2023 Jan; 13(1):93. PubMed ID: 36639673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
    Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
    Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased extra-renal urate excretion is a common cause of hyperuricemia.
    Ichida K; Matsuo H; Takada T; Nakayama A; Murakami K; Shimizu T; Yamanashi Y; Kasuga H; Nakashima H; Nakamura T; Takada Y; Kawamura Y; Inoue H; Okada C; Utsumi Y; Ikebuchi Y; Ito K; Nakamura M; Shinohara Y; Hosoyamada M; Sakurai Y; Shinomiya N; Hosoya T; Suzuki H
    Nat Commun; 2012 Apr; 3():764. PubMed ID: 22473008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.
    Matsuo H; Nakayama A; Sakiyama M; Chiba T; Shimizu S; Kawamura Y; Nakashima H; Nakamura T; Takada Y; Oikawa Y; Takada T; Nakaoka H; Abe J; Inoue H; Wakai K; Kawai S; Guang Y; Nakagawa H; Ito T; Niwa K; Yamamoto K; Sakurai Y; Suzuki H; Hosoya T; Ichida K; Shimizu T; Shinomiya N
    Sci Rep; 2014 Jan; 4():3755. PubMed ID: 24441388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.
    Takada T; Ichida K; Matsuo H; Nakayama A; Murakami K; Yamanashi Y; Kasuga H; Shinomiya N; Suzuki H
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):275-81. PubMed ID: 24940679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
    Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
    Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
    Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
    Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2.
    Matsuo H; Tsunoda T; Ooyama K; Sakiyama M; Sogo T; Takada T; Nakashima A; Nakayama A; Kawaguchi M; Higashino T; Wakai K; Ooyama H; Hokari R; Suzuki H; Ichida K; Inui A; Fujimori S; Shinomiya N
    Sci Rep; 2016 Aug; 6():31003. PubMed ID: 27571712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
    Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients.
    Nakashima A; Ichida K; Ohkido I; Yokoyama K; Matsuo H; Ohashi Y; Takada T; Nakayama A; Suzuki H; Shinomiya N; Urashima M; Yokoo T
    Hum Cell; 2020 Jul; 33(3):559-568. PubMed ID: 32180207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress and prospects for research on urate efflux transporter ABCG2].
    Ichida K
    Nihon Rinsho; 2014 Apr; 72(4):757-65. PubMed ID: 24796111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
    Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
    Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
    Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
    Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
    Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
    BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.